Last update: 03.07.2022 10:39 (GMT+3)

InMedica 2Y 5% bond (25.05.2022)

Vilnius market | First North Corporate bonds

INMB050023FA  |  ISIN LT0000405987

InMedica

InMedica

Name: UAB "InMedica" 
Core business: private healthcare services
Date of registration: 18 March 2004 
Auditor: UAB „Persense Audit“
Date of bond listing (First North): 9 March 2020 
Market: Nasdaq Vilnius

Management Board
Nerijus Drobavičius (Chairman), Kęstutis Broniukaitis (Secretary), Ashwin Roy, Josifs Apts, Stella Lapina, Aleksejs Tjurkins

Background Information

“InMedica”, which after the merger with the “MediCA” group now manages the network of 77 clinics, provides diagnostic, outpatient treatment, surgical, dental and other medical services. The “InMedica” group consists of 58 family medicine centres, 6 wide-profile, 7 specialized, 6 walk-in clinics and 3 laboratories.

After the merger, the “InMedica” group now has more than 2800 employees and provides healthcare services to more than 260,000 registered patients. “INVL Baltic Sea Growth Fund”, one of the largest private equity investment funds in the Baltics, owns 45 percent of the shares in the „InMedica“ network through its subsidiary “BSGF Sanus”, 40 percent of the shares is owned by “Repharm”, the largest private medical group in Latvia, and 15 percent – by the company “Litgaja”.

Contact Details 
Address: Ozo g. 12A, LT-08200 Vilnius                    
Telephone/Fax: +370 5 265 1852 
E–mail: info@inmedica.lt
Contact person: Kęstutis Broniukaitis (CEO), +370 5 265 1852

 

Documents

Documents

2020
March

Offer Document lt, 2 MB

Tradable Assets

Shares
Bonds
Funds

Market information

Statistics
Trading
Indexes
Auctions

Market Regulation

Rules and Regulations
Surveillance

Get Started

For Companies
For Investors
For Brokers/Members
For First North Advisers

News

Nasdaq News
Issuer News
Calendar

About Us

Nasdaq Baltic Market
Offices